Moderate riskFDA DrugClass II

Diovan valsartan 160 mg tablets recalled for failed dissolution

One lot of Novartis Diovan (valsartan) 160 mg tablets failed to meet dissolution specifications, which means the tablets may not dissolve properly in the body. This could affect how well the medication works. The affected lot (AV5913C, expiring 6/2027) was distributed nationwide.

From the FDA notice · Read the official notice ↗

What to do

  1. Check your Diovan bottle for lot number AV5913C and expiration date of 6/2027.
  2. If you have this lot, contact your pharmacy or doctor before stopping your medication.
  3. Do not stop taking your blood pressure medication without medical guidance.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Illnesses reported
None reported
Manufactured in
1 Health Plz, East Hanover, NJ, United States
Classification
Class II
Recall number
D-0746-2026

In the FDA's words

Description
Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34 Failed Dissolution Specifications Lot AV5913C, Expiry: 6/2027 Distribution: US Nationwide
Hazard
Failed Dissolution Specifications

Related topics

PotencyDrugsSold nationwideMore from FDA Drug